SONN Sonnet BioTherapeutics Net earnings per share growth this year

SONN (sonnetbio.com) - company brandmark

Sonnet BioTherapeutics focuses on organic research and seeking synergies with pharmaceutical industry behemoths. The year-over-year relative change in EPS helps assess revenue dynamics, where 69.10 shows the current value of the metric. Drug development efficiency is increasing through the implementation of AI protein modeling, while future financial potential is based on patents in the field of creating unique cytokines.

Sonnet BioTherapeutics Holdings (SONN): Net earnings per share growth this year from 07/04/2022 to 12/13/2025

Analytical breakdowns and data insights for company sonnetbio.com (SONN)

Brand item of Sonnet BioTherapeutics

Investors must evaluate long-term business sustainability through the lens of real returns. This indicator calculates the percentage deviation of current earnings per share from the same period last year. By analyzing the YoY net income per share trend, one can identify objective capital strength. For Sonnet BioTherapeutics (SONN), this metric is critical, as geopolitical instability and sanctions hinder international research. A decline in EPS growth rates here directly reflects logistical disruptions in immunotherapy development.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year